TB drug discovery: addressing issues of persistence and resistance
- 5 December 2003
- journal article
- review article
- Published by Elsevier in Tuberculosis
- Vol. 84 (1-2) , 45-55
- https://doi.org/10.1016/j.tube.2003.08.019
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant TuberculosisScience, 2002
- Mycobacterial persistence: adaptation to a changing environmentTrends in Microbiology, 2001
- Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyaseNature, 2000
- Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in miceMolecular Microbiology, 2000
- Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in miceNature, 1999
- Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature‐tagged transposon mutagenesisMolecular Microbiology, 1999
- Identification ofMycobacterium tuberculosisRNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS)Proceedings of the National Academy of Sciences, 1999
- Spread of Strain W, a Highly Drug‐Resistant Strain ofMycobacterium tuberculosis, Across the United StatesClinical Infectious Diseases, 1999
- Mechanisms of latency in Mycobacterium tuberculosisTrends in Microbiology, 1998
- 3 Persisting problems in tuberculosisPublished by Elsevier ,1998